Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
Fig 2
EBV antibodies in serum and DNA load in saliva and risk of conversion to CDMS.
Risk of conversion to clinically definite multiple sclerosis (CDMS; Kaplan-Meier curves) by tertiles of immunoglobulin (Ig)G antibodies to Epstein-Barr nuclear antigen 1 (EBNA-1, A) or viral capsid antigen (VCA, B) and presence or absence of Epstein-Barr virus (EBV) DNA in saliva (C).